Press Release Covis Pharma Group Announces Two Executive Management Team Appointments – Michelle Lock Joins Covis Pharma as Chief Operating Officer. – Also Announces Executive Leadership Transition with the Appointment of Sandy Loreaux as President, U.S. Business....
Press Release Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca – Enters into on an Exclusive Promotion and Distribution Agreement with Novartis for Distribution Rights to Seebri® Breezhaler® and Ultibro® Breezhaler®...
Press Release Covis Pharma Group Announces Two Executive Management Team Appointments -Appointment of Raghav Chari as Chief Innovation Officer to lead product portfolio lifecycle management. -Appointment of Nicolas Verbeke as Senior Vice President, Europe &...
Press Release Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca ZUG, SWITZERLAND, November 1, 2021 – Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic...
Press Release New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients Zug, Switzerland, October 4, 2021 – Covis Pharma GmbH (“Covis”) and Norgine B.V. (“Norgine”) today announced data...
